LONG-TERM COST EFFECTIVENESS OF SIROLIMUS REGIMEN COMPARED WITH CALCINEURIN INHIBITOR REGIMENS FOR IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION IN KOREA

被引：0
|
作者：
Song, H. J. [1 ]
Park, S. Y. [1 ]
Kang, S. H. [1 ]
Bae, J. Y. [1 ]
Lee, E. K. [1 ]
机构：
[1] Sook Myung Womens Univ, Seoul, South Korea
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)74059-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A199 / A200
页数：2
相关论文
共 50 条
  • [11] Calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolatmofetil after cardiac transplantation is safe and improves renal function significantly
    Groetzner, J
    Meiser, BM
    Mueller, M
    Kaczmarek, I
    Buehse, L
    Vogeser, M
    Schirmer, J
    Koglin, J
    Reichart, B
    CIRCULATION, 2002, 106 (19) : 325 - 325
  • [12] RENAL FUNCTION AFTER LIVER TRANSPLANTATION AT PAEDIATRIC AGE: EFFECTS OF LONG-TERM CALCINEURIN INHIBITOR TREATMENT
    Van der Vlist, Cato
    Van den Berg, A. P.
    Porte, R. J.
    Metselaar, H. J.
    Van Hoek, B.
    Beuers, U. H.
    Van Rheenen, P. F.
    Verkade, H. J.
    Besouw, M. T. P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 462 - 462
  • [13] Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation
    Creput, Caroline
    Blandin, Frederique
    Deroure, Benjamin
    Roche, Bruno
    Saliba, Faouzi
    Charpentier, Bernard
    Samuel, Didier
    Durrbach, Antoine
    LIVER TRANSPLANTATION, 2007, 13 (07) : 1004 - 1010
  • [14] Long-Term Outcomes Following Sirolimus Conversion after Renal Transplantation
    Soliman, Karim
    Mogadam, Emad
    Laftavi, Mark
    Patel, Sunil
    Feng, Lin
    Said, Meriem
    Pankewycz, Oleh
    IMMUNOLOGICAL INVESTIGATIONS, 2014, 43 (08) : 819 - 828
  • [15] Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
    McEwan, P
    Baboolal, K
    Conway, P
    Currie, CJ
    CLINICAL THERAPEUTICS, 2005, 27 (11) : 1834 - 1846
  • [16] Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: Intermediate experience in pediatric heart transplantation recipients
    Matthews, Kathleen
    Gossett, Jeffrey
    Kappelle, Peter Vande
    Jellen, Gina
    Pahl, Elfriede
    PEDIATRIC TRANSPLANTATION, 2010, 14 (03) : 402 - 408
  • [17] Early Steroid Withdrawal with a Sirolimus - and Mycophenolate-Based Calcineurin Inhibitor Minimization Regimen: Long-Term Results
    Conti, D. J.
    Conti, B. J.
    Dellehunt, R.
    Chandolias, N.
    Siparsky, N.
    Gallichio, M. H.
    TRANSPLANTATION, 2012, 94 (10) : 979 - 979
  • [18] Long-Term Results in Recipients of Late Conversion to a Calcineurin Inhibitor-Free Regimen with Everolimus After Kidney Transplantation
    Iwahara, Naoya
    Hotta, Kiyohiko
    Hirose, Takayuki
    Shinohara, Nobuo
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (04) : 803 - 808
  • [19] Kidney transplantation with sirolimus and mycophenolate mofetil based immunosuppression preserves renal structure and function compared to calcineurin inhibitor (CNI) drugs.
    Flechner, SM
    Solez, K
    Cook, DJ
    Burke, JT
    Rollin, H
    Mastoianni, B
    Savas, K
    Kurian, S
    Head, S
    Salomon, DR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 296 - 296
  • [20] Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation
    Earnshaw, Stephanie R.
    Graham, Christopher N.
    Irish, William D.
    Sato, Reiko
    Schnitzler, Mark A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (09): : 1807 - 1816
12345